申请人:——
公开号:US20030203909A1
公开(公告)日:2003-10-30
The present invention provides a compound represented by the formula (I)
1
wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R
1
, R
2
and R
3
are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X′ is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
本发明提供了一种由以下化学式(I)1所代表的化合物,其中环A为苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环B为苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2和R3分别为氢、烷基、卤素、羟基、烷氧基等,W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X′为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐和含有该化合物的药物。本发明的化合物对活化淋巴细胞的增殖具有优越的抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。